BREAKING
Sand artist Sudarsan Pattnaik creates 8-foot sculpture at Puri Beach to welcome PM ModiState secures Rs 53K cr investment proposalsMumbai records ‘Very Poor’ air as AQI touches 322, Delhi’s best October day in a decadeOdisha’s urbanisation rate will reach 40 pc by 2036, says CMMeerut blue drum murder: Muskan, lover Sahil move Allahabad HC against death sentenceFIR lodged after posters against govt crop up inside metro trainJSS Vardhan emerges as a strong contender in ‘The Traitors’Delhi has 237 licensed spas, but over 1,500 are operating‘Aeroplane’ song from Suriya’s ‘Scene’ impressesClass 12 student found burnt to death in school premises
Business

Dr Reddy’s Q2 profit falls 36% to Rs 913 cr

hellohimachalse@gmail.com 24 Oct 2026 1 day ago

New Delhi: Dr Reddy’s Laboratories on Friday reported a 36 per cent decline in consolidated net profit to Rs 913.4 crore for the September quarter. The company posted a consolidated net profit of Rs 1,426.8 crore a year ago, Reddy’s Laboratories said in a regulatory filing.

Its consolidated revenue in the second quarter stood at Rs 8,670.8 crore against Rs 8,805.1 crore in the year-ago period, it added. Total expenses in the quarter under review rose to Rs 3,252.1 crore from Rs 3,062.7 crore, the company said.

In a post-earnings call, Dr Reddy’s Laboratories CFO MV Narasimham said the company will launch semaglutide in 10 markets, including a relaunch in Canada, in November, which is expected to drive growth in the second half of the ongoing fiscal year.

It has received all regulatory approvals. Its Co-Chairman and Managing Director GV Prasad said, “We continued to improve the overall health of our business, delivering double-digit base business growth and EBITDA margins of over 20 per cent during the quarter.

We remain focused on strengthening our core businesses, enhancing productivity, and investing in strategic growth platforms to deliver consistent performance, while creating long-term value drivers”.

The company further said it will continue to explore opportunities for acquisitions and added that a few projects for partnerships are under discussion.

Related News